• No results found

Oral Contraceptive Reference Chart

N/A
N/A
Protected

Academic year: 2021

Share "Oral Contraceptive Reference Chart"

Copied!
5
0
0

Loading.... (view fulltext now)

Full text

(1)

Updated December 2014

Generic Name (Tier 1)

Brand Name

Estrogen/Progestin Component

MONOPHASIC

Aviane, Orsythia, Falmina, Lessina,

Delyla, Aubra, Sronyx, Lutera, levonorgestrel/EE

Alesse (not available)

EE 20 mcg/ Levonorgestrel 0.1 mg

Apri, Solia, Reclipsen, Enskyce, Emoquette, Desogestrel/EE

Ortho-Cept, Desogen

EE 30 mcg/ Desogestrel 0.15 mg

Levora, Portia, Altavera, Chateal, Kurvelo, Marlissa, Levonorgestrel/EE

Nordette,

Levlen (not available)

EE 30 mcg/ Levonorgestrel 0.15 mg

Low-Ogestrel, Cryselle, Norgestrel/EE, Elinest Lo/Ovral EE 30 mcg/ Norgestrel 0.3 mg Junel 1.5/30, Microgestin 1.5/30, Gildess 1.5/30, Larin 1.5/30 Loestrin 1.5/30 EE 30 mcg/ Norethindrone 1.5 mg Junel Fe 1.5/30, Microgestin Fe 1.5/30, Gildess Fe 1.5/30, Larin Fe 1.5/30 Loestrin Fe 1.5/30 EE 30 mcg/ Norethindrone 1.5 mg/ Fe 75 mg

Junel 1/20, Microgestin 1/20, Gildess 1/20, Larin 1/20, Norethindrone/EE Loestrin 1/20 EE 20 mcg/ Norethindrone 1 mg Junel Fe 1/20, Microgestin Fe 1/20, Gildess Fe 1/20, Larin Fe 1/20, Norethindrone/EE/Fe, Tarina Fe Loestrin Fe 1/20 EE 20 mcg/ Norethindrone 1 mg/ Fe 75 mg

Sprintec, Previfem, MonoNessa,

Norgestimate/EE, Estarylla, Mono-Linyah

Ortho-Cyclen EE 35 mcg/ Norgestimate 0.25 mg

Balziva, Zenchent, Briellyn, Philith, Gildagia, Vyfemla

Ovcon-35 EE 35 mcg/ Norethindrone 0.4 mg

Zeosa, Zenchent Fe, Wymzya Fe (chew or swallow)

Femcon Fe (chew or swallow)

EE 35 mcg/ Norethindrone 0.4 mg/ Fe 75 mg

Necon 0.5/35, Nortrel 0.5/35, Wera 0.5/35

Brevicon, Modicon EE 35 mcg/ Norethindrone 0.5 mg

Necon 1/35,Nortrel 1/35,Cyclafem 1/35, Alyacen 1/35,Dasetta 1/35,Pirmella 1/35

Ortho-Novum 1/35, Norinyl 1+35

EE 35 mcg/ Norethindrone 1 mg

Zovia 1/35E, Kelnor 1/35

Demulen 1/35 (not available)

EE 35 mcg / Ethynodiol diacetate 1 mg

None

(2)

Updated December 2014

None

Ovcon-50 EE 50 mcg/ Norethindrone 1 mg

None

Zovia 1/50E EE 50 mcg/ Ethynodiol diacetate 1 mg

None

Norinyl 1 + 50, Necon 1/50

Mestranol 50 mcg/ Norethindrone 1 mg

Ocella, Syeda, Zarah, Drospirenone/EE

Yasmin EE 30 mcg/ Drospirenone 3 mg None Safyral *Non-formulary EE 30 mcg/ Drospirenone 3 mg/ Levomefolate calcium 0.451 mg

BIPHASIC

Kariva, Azurette, Viorele, Pimtrea

desogestrel/EE

Mircette EE 20, 10 mcg / Desogestrel 0.15 mg Extended Cycle

 Active tablet (EE 20 mcg): 21 days

 Inactive tablet: 2 days

 Active EE only (10 mcg): 5 days None

Necon 10/11 EE 35 mcg/ Norethindrone 0.5, 1 mg Extended Cycle

 Active tablet (Nor 0.5 mg): 10 days

 Active tablet (Nor 1 mg): 11 days

 Inactive tablet: 7 days

TRIPHASIC

Tilia Fe, Tri-Legest Fe

Estrostep Fe EE 20, 30, 35 mcg/ Norethindrone 1 mg/ Fe 75 mg Extended Cycle

 Active tablet (EE 20 mcg): 5 days

 Active tablet (EE 30 mcg): 7 days

 Active tablet (EE 35 mcg): 9 days

 Inactive tablet (Fe only): 7 days Trivora, Enpresse, Myzilra, Levonest

Tri-Levlen (not available)

EE 30, 40 mcg/ levonorgestrel 0.05, 0.075, 0.125mg Extended Cycle

 Active tablet (EE 30, Lev 0.05): 6 days

 Active tablet (EE 40, Lev 0.075): 5 days

 Active tablet (EE 30, Lev 0.125): 10 days

 Inactive tablet: 7 days Tri-Sprintec, Trinessa,

Tri-Previfem, Tri-Linyah, Tri-Estarylla, Norgestimate/EE

Ortho Tri-Cyclen EE 35 mcg/ Norgestimate 0.18, 0.215, 0.25 mg Extended Cycle

 Active tablet (Nor 0.18): 7 days

 Active tablet (Nor 0.215): 7 days

 Active tablet (Nor 0.25): 7 days

(3)

Updated December 2014

None

Ortho Tri-Cyclen LO EE 25 mcg/ Norgestimate 0.18, 0.215, 0.25 mg Extended Cycle

 Active tablet (Nor 0.18): 7 days

 Active tablet (Nor 0.215): 7 days

 Active tablet (Nor 0.25): 7 days

 Inactive tablet: 7 days Aranelle , Leena

Tri-Norinyl EE 35 mcg/ Norethindrone 0.5, 1 mg Extended Cycle

 Active tablet (Nor 0.5): 7 days

 Active tablet (Nor 1): 9 days

 Active tablet (Nor 0.5): 5 days

 Inactive tablet: 7 days Velivet, Cesia, Caziant

Cyclessa EE 25 mcg/ Desogestrel 100, 125, 150 mcg Extended Cycle

 Active tablet (Des 100): 7 days

 Active tablet (Des 125): 7 days

 Active tablet (Des 150): 7 days

 Inactive tablet: 7 days Necon 7/7/7, Nortrel 7/7/7, Cyclafem

7/7/7, Alyacen 7/7/7, Dasetta 7/7/7, Pirmella 777

Ortho-Novum 7/7/7 EE 35 mcg/ Norethindrone 0.5, 0.75, 1 mg Extended Cycle

 Active tablet (Nor 0.5): 7 days

 Active tablet (Nor 0.75): 7 days

 Active tablet (Nor 1): 7 days

 Inactive tablet: 7 days

FOUR-PHASIC

None

Natazia Estradiol valerate 3, 2, 1 mg/ Dienogest 2, 3 mg Extended Cycle

 Active estrogen only (EV 3 mg): 2 days

 Active tab (EV 2mg, Dienogest 2mg): 5 days

 Active tab (EV 2mg, Dienogest 3mg): 17 days

 Active estrogen only (EV 1mg): 2 days

 Inactive tablet: 2 days

EXTENDED-CYCLE

MONOPHASIC

None Generess Fe (chewable only) * Non-formulary EE 25 mcg/ Norethindrone 0.8 mg/ Fe 75mg Extended Cycle:

 Active tablet: 24 days

 Inactive tablet: 4 days

(4)

Updated December 2014

Lomedia 24 Fe, Norethindrone/EE/Fe

Extended Cycle:

 Active tablet: 24 days

 Inactive tablet: 4 days None

Minastrin 24 Fe (chewable)

EE 20 mcg/ Norethindrone 1 mg/ Fe 75 mg Extended Cycle:

 Active tablet: 24 days

 Inactive tablet: 4 days None Beyaz *Non-formulary EE 20 mcg/ Drospirenone 3 mg/ Levomefolate calcium 0.451 mg Extended Cycle

 Active tablet: 24 days

 Inactive tablet: 4 days Gianvi, Loryna, Vestura, Nikki

Yaz EE 20 mcg/ Drospirenone 3 mg

Extended Cycle:

 Active tablet: 24 days

 Inactive tablet: 4 days

MULTIPHASIC

None Lo Loestrin Fe *Non-formulary EE 10 mcg/ Norethindrone 1 mg/ Fe 75mg Extended Cycle:

 Active tablet: 24 days

 Active EE only: 2 days

 Inactive tablet: 2 days None Lo Minastrin Fe (chewable) *Non-formulary EE 10 mcg/ Norethindrone 1 mg/ Fe 75mg Extended Cycle:

 Active tablet: 24 days

 Active EE only: 2 days

 Inactive tablet: 2 days Amethia, Camrese, Daysee

Seasonique EE 30, 10 mcg/ Levonorgestrel 0.15 mg Extended Cycle:

 Active tablet: 84 days

 Active EE only (10 mcg): 7 days Camrese Lo, Amethia Lo,

Levonorgestrel/EE

LoSeasonique EE 20, 10 mcg/ Levonorgestrel 0.1 mg Extended Cycle:

 Active tablet: 84 days

 Active EE only (10 mcg): 7 days Quasense, Jolessa, Introvale,

levonorgestrel/EE

Seasonale EE 30 mcg/ Levonorgestrel 0.15 mg Extended Cycle:

(5)

Updated December 2014

 KEY

o EE = Ethinyl Estradiol

o EV = Estradiol Valerate

o Fe = Ferrous Fumarate

 Inactive tablet: 7 days None

Quartette

*Non-formulary

EE 20, 25, 30, 10 mcg/ Levonorgestrel 0.15 mg Extended Cycle

 Active tablet (EE 20 mcg): 42 days

 Active tablet (EE 25 mcg): 21 days

 Active tablet (EE 30 mcg): 21 days

 Active EE only (10 mcg): 7 days

CONTINUOUS CYCLE (no hormone-free interval)

None

Amethyst,

Lybrel (not available )

EE 20 mcg/ Levonorgestrel 90 mcg

 Take daily

PROGESTIN-ONLY PILLS

Jolivette, Errin, Camila, Nora-BE, Heather, Jencycla, Deblitane, Sharobel, Lyza, Norlyroc, Norethindrone

Ortho Micronor, Nor-QD

Norethindrone 0.35 mg

EMERGENCY CONTRACEPTIVES

Next Choice, levonorgestrel

Plan B Levonorgestrel 0.75 mg (2 pills)

 Take 2nd tablet 12 hours after the 1st Next Choice One Dose, My Way,

levonorgestrel

Plan B One-Step

Levonorgestrel 1.5 mg (1 pill)

None

References

Related documents

In contrast, international banks with centralized funding concentrated at their HQ in the home country or in international financial centers, which rely more on cross-border lending

This study has demonstrated that rs3755557, a SNP in the promoter region of GSK3B , modulates gene expression by altered binding of transcription factors and is significantly

A first necessary condition to hold a doctor liable is that the doctor is at fault , that is to say that he failed to act according to the required standard of care (a

To summarize, conscious and unconscious thinkers did neither differ in the number of ideas listed nor in the average creativity of their ideas; however, participants in the

The comparison of cloud base heights between the satellite sensors and the ground observations for the SGP site showed the best correlation of the four ground sites, with an

The proposed design methodology was implemented to the IT infrastructure of electric power utility management systems, where the feeder reconfiguration function

BT needs to inculcate the importance of CRM and encourage their sales advisors to incorporate and use relevant customer data when they interact with the individual customer to

In this meta-analytic study, the effect coefficients of the studies (Akay, 2006; Çoban, 2004; Eren, 2011; Kaçar, 2012; Ülger, 2011) related to the effects of problem-